BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 30986362)

  • 1. Cardiovascular Risk and Risk Factor Management in Type 2 Diabetes Mellitus: A Population-Based Cohort Study Assessing Sex Disparities.
    Wright AK; Kontopantelis E; Emsley R; Buchan I; Mamas MA; Sattar N; Ashcroft DM; Rutter MK
    Circulation; 2019 Jun; 139(24):2742-2753. PubMed ID: 30986362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gender disparities in diabetes and coronary heart disease medication among patients with type 2 diabetes: results from the DIANA study.
    Krämer HU; Raum E; Rüter G; Schöttker B; Rothenbacher D; Rosemann T; Szecsenyi J; Brenner H
    Cardiovasc Diabetol; 2012 Jul; 11():88. PubMed ID: 22838970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. National survey: Evaluation of cardiovascular risk factors in Thai patients with type 2 diabetes and chronic kidney disease after the development of cardiovascular disease.
    Changsirikulchai S; Sangthawan P; Janma J; Sripaiboonkij N; Rattanamongkolgul S; Thinkhamrop B
    Nephrology (Carlton); 2018 Jan; 23(1):53-59. PubMed ID: 27608176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gender-Related Differences in the Control of Cardiovascular Risk Factors in Primary Care for Elderly Patients With Type 2 Diabetes: A Cohort Study.
    Al-Salameh A; Bucher S; Bauduceau B; Benattar-Zibi L; Berrut G; Bertin P; Corruble E; Danchin N; Derumeaux G; Doucet J; Falissard B; Forette F; Hanon O; Ourabah R; Pasquier F; Pinget M; Ringa V; Becquemont L
    Can J Diabetes; 2018 Aug; 42(4):365-371.e2. PubMed ID: 29037572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Socioeconomic position and cardiovascular risk factors among people with screen-detected Type 2 DM: six-year follow-up of the ADDITION-Denmark trial.
    Dalsgaard EM; Vestergaard M; Skriver MV; Borch-Johnsen K; Lauritzen T; Sandbaek A
    Prim Care Diabetes; 2014 Dec; 8(4):322-9. PubMed ID: 24613817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sex Differences in Cardiovascular Effectiveness of Newer Glucose-Lowering Drugs Added to Metformin in Type 2 Diabetes Mellitus.
    Raparelli V; Elharram M; Moura CS; Abrahamowicz M; Bernatsky S; Behlouli H; Pilote L
    J Am Heart Assoc; 2020 Jan; 9(1):e012940. PubMed ID: 31902326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular risk factors among high-risk individuals attending the general practice at king Abdulaziz University hospital: a cross-sectional study.
    Ghamri RA; Alzahrani NS; Alharthi AM; Gadah HJ; Badoghaish BG; Alzahrani AA
    BMC Cardiovasc Disord; 2019 Nov; 19(1):268. PubMed ID: 31775642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular risk management in type 2 diabetes of more than 10-year duration: Results of Polish ARETAEUS2-Grupa Study.
    Leśniak W; Bała MM; Płaczkiewicz-Jankowska E; Topór-Mądry R; Jankowski M; Sieradzki J; Banasiak W;
    Cardiol J; 2015; 22(2):150-9. PubMed ID: 25299503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of preventative cardiovascular therapies on coronary artery disease in people with and without type 2 diabetes: a propensity-matched score study.
    Kiburg KV; MacIsaac AI; McCluskey GE; Sundararajan V; MacIsaac RJ
    BMC Cardiovasc Disord; 2021 Sep; 21(1):463. PubMed ID: 34565341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antidiabetic and cardiovascular drug utilisation in patients diagnosed with type 2 diabetes mellitus over the age of 80 years: a population-based cohort study.
    Hamada S; Gulliford MC
    Age Ageing; 2015 Jul; 44(4):566-73. PubMed ID: 26015163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gender-based treatment outcomes in diabetic hypertension.
    Damanhori A; Al Khaja K; Sequeira RP
    J Postgrad Med; 2008; 54(4):252-8. PubMed ID: 18953141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sex-specific differences in metabolic control, cardiovascular risk, and interventions in patients with type 2 diabetes mellitus.
    Kautzky-Willer A; Kamyar MR; Gerhat D; Handisurya A; Stemer G; Hudson S; Luger A; Lemmens-Gruber R
    Gend Med; 2010 Dec; 7(6):571-83. PubMed ID: 21195357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in the Prescription of Glucose-Lowering Medications in Patients With Type 2 Diabetes Mellitus After a Cardiovascular Event: A Call to Action From the DATAFILE Study.
    Fadini GP; Frison V; Simioni N; Lapolla A; Gatti A; Bossi AC; Del Buono A; Fornengo P; Gottardo L; Laudato M; Perseghin G; Bonora E; Avogaro A
    J Am Heart Assoc; 2019 Jul; 8(14):e012244. PubMed ID: 31269877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sex-related disparities in the incidence and outcomes of hemorrhagic stroke among type 2 diabetes patients: a propensity score matching analysis using the Spanish National Hospital Discharge Database for the period 2016-18.
    Lopez-de-Andres A; Jimenez-Garcia R; Hernández-Barrera V; Jiménez-Trujillo I; de Miguel-Yanes JM; Carabantes-Alarcon D; de Miguel-Diez J; Lopez-Herranz M
    Cardiovasc Diabetol; 2021 Jul; 20(1):138. PubMed ID: 34243780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular risk management in type 2 diabetes mellitus: A joint position paper of the Italian Cardiology (SIC) and Italian Diabetes (SID) Societies.
    Avogaro A; Barillà F; Cavalot F; Consoli A; Federici M; Mancone M; Paolillo S; Pedrinelli R; Perseghin G; Perrone Filardi P; Scicali R; Sinagra G; Spaccarotella C; Indolfi C; Purrello F
    Nutr Metab Cardiovasc Dis; 2021 Jun; 31(6):1671-1690. PubMed ID: 33994263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prescription of lipid-lowering medications for patients with type 2 diabetes mellitus and risk-associated LDL cholesterol: a nationwide study of guideline adherence from the Swedish National Diabetes Register.
    Karlsson SA; Franzén S; Svensson AM; Miftaraj M; Eliasson B; Andersson Sundell K
    BMC Health Serv Res; 2018 Nov; 18(1):900. PubMed ID: 30486824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Difficulties in reaching therapeutic goals for hypertension and dysplipidaemia in patients with type 2 diabetes in general practice.
    Knudsen ST; Mosbech TH; Hansen B; Kønig E; Johnsen PC; Kamper AL
    Dan Med J; 2013 Dec; 60(12):A4740. PubMed ID: 24355449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gender differences in cardiovascular disease risk factors, treatments and complications in patients with type 2 diabetes: the RIACE Italian multicentre study.
    Penno G; Solini A; Bonora E; Fondelli C; Orsi E; Zerbini G; Trevisan R; Vedovato M; Gruden G; Laviola L; Nicolucci A; Pugliese G;
    J Intern Med; 2013 Aug; 274(2):176-91. PubMed ID: 23565931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Awareness, treatment, and control of major cardiovascular risk factors in a small-scale Italian community: results of a screening campaign.
    Omboni S; Carabelli G; Ghirardi E; Carugo S
    Vasc Health Risk Manag; 2013; 9():177-85. PubMed ID: 23662063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accuracy of anthropometric indexes of obesity to predict diabetes mellitus type 2 among men and women with hypertension.
    Marcadenti A; Fuchs SC; Moreira LB; Wiehe M; Gus M; Fuchs FD
    Am J Hypertens; 2011 Feb; 24(2):175-80. PubMed ID: 20885370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.